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ABSTRACT 
 
 
 Ophidiomyces ophiodiicola (formerly Chrysosporium ophiodiicola), the causative agent 
of ophidiomycosis (Snake Fungal Disease; SFD), is a serious emerging fungal pathogen causing 
morbidity and mortality in both wild and captive snakes. SFD has been documented in terrestrial 
and aquatic captive snake populations in the United Kingdom, Germany, Australia, and North 
America. The most common presenting clinical signs of SFD infection include severe dermatitis, 
facial swelling, and emaciation. It was previously thought that lesions associated with SFD were 
limited to the skin of the head and neck; however, recent reports show well-documented cases of 
SFD skin lesions throughout many regions of the body. These case reports predominantly focus 
on grossly visible cutaneous lesions. Rarely, systemic lesions within the lungs, spleen, liver, eye, 
and kidneys have been documented. SFD can be fatal; however, the complications of this disease 
leading to mortality, particularly concerning the pathology and role of comorbidities, are poorly 
understood. This lack of understanding limits the ability and success of clinicians and 
rehabilitators to treat snakes infected with SFD and inhibits our ability to prevent transmission in 
both captive and wild settings. Treatment and preventing transmission are particularly important 
for those species that are endangered or threatened.   
 The aim of this study was to gain insight into the cutaneous disease severity, subclinical 
manifestation, systemic involvement, and comorbidities associated with SFD. I hypothesized the 
following: 1) the systematic mapping protocol derived from this methodology will identify 
characteristic lesions of SFD in a cohort of wild-caught Lake Erie water snakes, 2) as the number 
of survey sections affected by SFD increases, so too will the overall cutaneous severity score, 3) 
histopathological examination will allow for detection of subclinical lesions that are not 
associated with gross disease, 4) individuals with visceral granulomas will have more severe 
 iii 
cutaneous disease, 5) there will be a range of infectious and non-infectious conditions associated 
with ophidiomycosis, and finally 6) individuals with decreased visceral adipose tissue will have a 
higher overall cutaneous severity score as well as head cutaneous severity score than those with 
adequate visceral adipose tissue.   
 This study established a detailed necropsy protocol that identified a positive correlation 
between cutaneous severity and a wider distribution in cutaneous lesions throughout an 
individual. The results also highlighted a high prevalence (45.3%) of subclinical, or grossly 
inapparent, cutaneous lesions as well as a lack of correlation between cutaneous severity and 
visceral granulomas. Finally, this study documented numerous comoribidities, including 
verminous pneumonia, heterophilic enteritis and splenitis, cutaneous mites, and coccidiosis. The 
most-prevalent comorbidity was decreased visceral adipose tissue stores which was not 
associated with cutaneous disease severity. The results of this study suggest that SFD alone is 
able to cause mortality; however the pathogenesis by which O. ophiodiicola does this remains 
unclear. Additionally, these results provide a process for those studying SFD to evaluate 
cutaneous severity of disease with clincal (grossly visible) and subclinical (grossly absent) 
disease.  
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CHAPTER 1: LITERATURE REVIEW 
Introduction 
 Ophidiomyces ophiodiicola, the causative agent of Snake Fungal Disease (SFD), is of 
increasing importance to wildlife conservationists and researchers. Currently, SFD meets the 
criteria of an emerging infectious disease in snakes, such that O. ophiodiicola has been recently 
observed (Rajeev et al., 2009), infects a wide range of snake species (Burbrink et al., 2017), has 
ecotypes with high virulence (Allender et al., 2012), and is both an opportunistic and generalist 
pathogen (Allender et al., 2015d). Although this fungus has likely been present for decades, new 
understanding of the disease and its clinical signs, as well as increased surveillance, suggest that 
there has been a rapid increase in the total number of individual snakes affected within the past 2 
decades (U.S. Fish and Wildlife Service, 2011). This organism has been implicated as a factor in 
previous snake population declines and proves to be difficult to control or eradicate in endemic 
soils (Allender et al., 2016a; Clark et al., 2011; Franklinos et al., 2017). Recently, researchers 
have focused their efforts to gain a better understanding of O. ophiodiicola pathogenesis, 
molecular characteristics, and possible treatments in the hope of controlling spread of disease.  
Background 
 The first case of O. ophiodiicola was noted in 1985 from a captive ball python in England 
(Paré et al., 2016; Sigler et al., 2013), and this organism has since been documented in over 30 
species throughout North America and Europe (Franklinos et al., 2017; Lorch et al., 2016; Sigler 
et al., 2013). Affected snakes may have varying clinical signs predominantly affecting the 
integument, but these lesions can progress to widespread, systemic infection that results in 
mortality at both the individual and population level (Baker et al., 2019; Lorch et al., 2016).  
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 O. ophiodiicola is a member of the order Onygenales within the family of Onygenaceae. 
This family contains several fungal pathogens including Histoplasma capsulatum and 
Coccidioides immitis. Both of these fungi are well-studied and documented as causing diseases 
in domestic mammals, particularly canids and felids (Kerl, 2003; Sigler et al., 2013). Initially, O. 
ophiodiicola was thought to be the same species of Onygenaceae associated with Chrysosporium 
anamorph Nannizziopsis vriesii (CANV) complex, which causes skin lesions such as cutaneous 
crusting, thickened or raised scales, ulceration, and even necrosis in a variety of squamate 
reptiles. After full-genome sequencing and comparison between culture characteristics, it is now 
known that O. ophiodiicola, although closely related to CANV, is a distinct genus that currently 
contains only one species (Sigler et al., 2013).  
 O. ophiodiicola is a saprophytic fungus that is remarkably stable within various 
environments (Allender et al., 2015d). Although the genome has been sequenced (Ohkura et al., 
2017), few studies have attempted to further describe the specific characteristics that allow O. 
ophiodiicola to thrive as a pathogen. Notably, a study performed by Allender et al. (2015d) 
found that O. ophiodiicola is able to grow in environments of a wide range of pH (5-11), is able 
to use multiple complex carbon and nitrogen sources, and is water-stress tolerant. Together, these 
factors lend further support to this organism’s ability to survive in a broad range of 
microenvironments. This study also found that O. ophiodiicola isolates were positive for urease 
among other enzymes (e.g. gelatinase, b-glucosidase, lipase, lipase/esterase, and keratinase). 
Urease has been proposed to be a virulence factor in other fungal pathogens; its ammonia 
biproduct is toxic to host tissues, aiding systemic dissemination (Casadevall, 2003).  
 In order to identify O. ophiodiicola in fungal culture or histopathologically, it is 
important to understand this organism’s lifecycle. Currently, there is no identified sexual state of 
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this fungus (Rajeev et al., 2009). O. ophiodiicola exists in 3 distinct morphologies: hyphae, 
arthroconidia, and aleurioconidia (Rajeev et al., 2009; Sigler et al., 2013). Fungal hyphae are the 
main mode for vegetative growth for O. ophiodiicola, whereas arthroconidia and aleurioconidia 
represent asexual reproductive states of the organism (Rajeev et al., 2009). Arthroconidia are 
produced by segmentation of preexisting fungal hyphae (schizolytic dehiscence) (Sigler et al., 
2013), and aleurioconidia are produced by lysis of the supporting fungal hyphae (rhexolytic 
dehiscence) (Rajeev et al., 2009). It is through these two asexual morphologies that the organism 
is presumed to initially infect the snake host and initiate cutaneous disease (Rajeev et al., 2009). 
Initial infection may occur via contact with soil containing O. ophiodiicola or from direct or 
indirect contact with individual snakes that have cutaneous ophidiomycosis, whether they are 
subclinical carriers or affected individuals.  
 All three morphologies can be identified in both fungal culture and within tissues, both 
cytologically and histologically. In culture, O. ophiodiicola colonies are yellow-white and 
moderately fast growing. Hyphae are narrow, branched, and septate, and occasionally form 
racquet mycelia. Aluerioconidia can be sessile or borne on short stalks and are hyaline, smooth, 
and cylindrical. Arthroconidia are formed in chains via fragmentation of hyphae, and can be 
terminal (on the end of hyphae) or intercalary (within hyphae) (Sigler et al., 2013).  
Histologically, fungal hyphae are up to 5 µm in diameter, have parallel walls, are septate with 
variably present terminal bulbous dilations, exhibit frequent acute-angle branching, and have 
transverse septa (Baker et al., 2019). Histologically, fungal aleurioconidia are 2-8 µm x 2-3 µm 
and are negatively staining (Ohkura et al., 2016) and fungal arthroconidia are approximately 2 x 
4 µm, cylindrical, and tend to form aggregates along the skin surface at the air-tissue interface 
(Baker et al., 2019; Steeil et al., 2018). It is this arthroconidial form, which can be distinctly 
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identified on routine histopathology, that allows confirmation that Ophidiomyces ophiodiicola, as 
opposed to other fungi, are present in reptilian skin (Baker et al., 2019). Additional histochemical 
staining, including Gomori methenamine silver and periodic acid-Schiff, can be useful in 
highlighting distinct fungal morphology.  
Epidemiology 
 O. ophiodiicola has been definitively isolated in over 30 snake species, including those 
with and without evidence of clinical disease; both captive and free-ranging snakes throughout 
North America have been affected (Baker et al., 2019). As of 2015, the known United States 
distribution of O. ophiodiicola in native wild snake populations was documented throughout the 
midwestern and eastern U.S. with cases confirmed in Minnesota, Wisconsin, Michigan, Illinois, 
Ohio, Pennsylvania, Virginia, Tennessee, Kentucky, South Carolina, Georgia, Alabama, Florida, 
New Jersey, New York, Massachusetts, and New Hampshire (Allender et al., 2015d). Since then, 
the fungus has been detected in native free-ranging snakes from additional states, including 
Louisiana and California, suggesting that this organism has a much wider geographical range 
than initially presumed. In 2016, a wild juvenile water snake in Louisiana was found 
inappropriately basking (basking during seasons of brumation) and had severe cutaneous 
crusting, ulceration, and necrosis as well as emaciation; PCR testing of cutaneous crusts were 
positive for O. ophiodiicola (Glorioso et al., 2016). In 2019, a free-ranging kingsnake in 
California was found to have severe cutaneous disease as well as emaciation that was attributed 
to O. ophiodiicola via PCR of a whole-body swab (Haynes et al., in press). Within the United 
States, SFD has also been documented in captive snake populations in Illinois, Virginia, Georgia, 
Florida, Wisconsin, New York, California, Maryland, New Mexico, and Arizona (Allender et al., 
2015). In addition to this organism’s prevalence throughout North America, isolates have been 
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retrieved from macroscopic skin lesions from captive snakes located in England, Germany, and 
Australia (Franklinos et al., 2017; Sigler et al., 2013). Retrospectively, real-time PCR detected O. 
ophiodiicola on carcasses or molted skin collected from wild snakes in Great Britain and the 
Czech Republic (Franklinos et al., 2017). This study concluded that O. ophiodiicola is widely 
distributed throughout England and Wales, and is also present in mainland Europe. In this study, 
however, only the fungal organism was identified, not cutaneous lesions. Therefore, this 
retrospective analysis only confirms that O. ophiodiicola is present within these regions and does 
not confirm presence of actual disease.   
 O. ophiodiicola causes disease across numerous and varied taxa of snakes (Burbrink et 
al., 2017). SFD has been documented in snakes that inhabit various environments (e.g., aquatic, 
semiaquatic, terrestrial, fossorial), have differing reproductive mechanisms (viviparous vs. 
oviparous), activity patterns (diurnal vs. nocturnal), brumation habits (communal vs. solitary), 
and diets (e.g. primarily consuming vertebrates, other snakes, and predominantly invertebrates) 
(Burbrink et al., 2017). As in cases of severe emerging fungal pathogens, it is suspected that O. 
ophiodiicola's broad host range plays a major role in its ability to cause catastrophic effects 
within host populations (Lorch et al., 2016).  
 While the exact number of snakes that have succumbed to SFD-related disease 
throughout the United States is not yet known, its presence and effect on several specific snake 
populations have been recently documented. In Illinois, SFD has been associated with the 
population decline of Eastern Massasauga rattlesnakes, which are a threatened species under the 
Endangered Species Act of 2015 (Allender et al., 2016a). This disease has also been documented 
in populations of Lake Erie water snakes, Timber rattlesnakes, and prairie kingsnakes (Clark et 
al., 2011; Department of Defense Legacy Resource Management Program, 2019; U.S. Fish and 
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Wildlife Service, 2011). Though ophidiomycosis could not be confirmed as the cause of the 
population decline, the Lake Erie water snake population in the Western Basin Lake Erie Islands 
dropped by an estimated 18% in a single year following an outbreak of SFD (U.S. Fish and 
Wildlife Service, 2011). A suspected outbreak in New Hampshire Timber rattlesnakes reduced 
that population by 50% within 1 year (Clark et al., 2011). These outbreaks illustrated differential 
disease severity that could have potential detrimental effects on population stability (Allender et 
al., 2015; Dolinski et al., 2014; Last et al., 2016). 
Clinical Signs/Gross Lesions 
 The most characteristic SFD lesions are associated with the skin. Subtle changes include 
discoloration, roughened or displaced scales, accelerated ecdysis cycles, and epidermal flaking 
and crusting (Baker et al., 2019). These lesions can progress to increased epidermal crusting, 
epidermal erosion/ulceration, and inflammation (predominantly heterophilic) of the epidermis, 
dermis, and/or subcutis (Allender et al., 2015a, Baker et al., 2019). More-severe cutaneous 
infections may lead to dermal granuloma formation, increased soft tissue inflammation, and 
extension of inflammation into surrounding bone (Baker et al., 2019; Lorch et al., 2016). While 
cutaneous infections can be quite severe and are generally the lesions that are readily and most 
easily identified in surveyed populations, SFD can cause systemic infection (Baker et al., 2019; 
Robertson et al., 2016; Steeil et al., 2018). Systemic infection is typically characterized by 
discrete granuloma formation within the body wall, subcutis, and multiple visceral organs 
including the eye, liver, lungs, kidneys, intestinal mesentery, gastrointestinal system, and soft 
tissues of the head, tail, and cloaca (Baker et al., 2019; Lorch et al., 2016).  
 It should be noted that there are cases of snakes with O. ophiodiicola qPCR-positive skin 
swabs in the absence of gross lesions or other clinical signs of disease. These cases may 
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represent early or recovering forms of disease or may represent asymptomatic carriers of the 
fungus (Baker et al., 2019; McKenzie et al., 2019).  
Pathogenesis 
 Because of the fairly recent characterization of  O. ophiodiicola, there is still much work 
to be done to discern the underlying mechanism by which this organism causes death. While it 
was previously thought that O. ophiodiicola only infected the skin with predilection for the head 
and tail (Lorch et al., 2016), it is now known that this organism can cause severe cutaneous 
disease in any region of the body and is capable of systemic infection (Clark et al., 2011; Tetzlaff 
et al., 2015). The initial source of infection by O. ophiodiicola appears to be through the stratum 
corneum (Lorch et al., 2015). Although a break in the epidermis facilitates fungal invasion of the 
site, it is not necessary (Allender et al., 2015a; Lorch et al., 2015). Initial infection within the 
epidermis causes the host to mount an immune response and early lesions consist of epidermal 
edema and heterophilic inflammation (Lorch et al., 2015). In mild infections of seemingly 
healthy snakes, molting interval time is decreased, allowing individuals to rid themselves of the 
superficial infection (Lorch et al., 2015). Molting is an important host defense mechanism in 
snakes, where the superficial-most keratin overlying the stratum corneum of the epidermis is 
shed into the environment, thereby eliminating superficial bacteria and fungi (Lorch et al., 2015). 
Although increased molting lowers the risk of O. ophiodiicola infection, in cases where low 
numbers of fungi remain in the underlying epidermis after molting, individuals may be at risk for 
chronic infection (Lorch et al., 2015).  
 Multiple case studies have documented the presence of SFD-associated granulomas 
within the subcutis, skeletal muscle, and viscera (Allender et al., 2015d; Lorch et al., 2016; Steeil 
et al., 2018); however, the pathogenesis of systemic spread remains unknown. Systemic SFD-
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associated granulomas that have been documented include those affecting the pancreas, lung, 
eye, gingival stroma, liver, and spleen (Allender et al., 2011; Dolinski et al., 2014; Ohkura et al., 
2016; Steeil et al., 2018; Vissiennon et al., 1999). In most cases of subcuticular, intramuscular, or 
visceral SFD-associated lesions, there are also cutaneous SFD-associated lesions within the same 
individual. However, in 2018, there was a report of a captive Eastern diamondback rattlesnake 
(Crotalus adamanteus) with multiple intramuscular and subcutaneous granulomas as well as 
pulmonary granulomas attributable to SFD without associated cutaneous lesions (Dolinksi et al., 
2014; Steeil et al., 2018). This case further highlights knowledge gaps in understanding O. 
ophiodiicola dissemination.  
 Multiple hypotheses have been proposed for how SFD causes death in infected 
individuals. One hypothesis suggested that severe infection of the head causes facial necrosis and 
distortion, altering the individual’s vision and olfactory sensation and therefore its ability to hunt 
prey; it is presumed that in these cases, wild snakes die of starvation rather than directly due to 
SFD infection (Lorch et al., 2016). This hypothesis is supported by the fact that emaciation is 
commonly seen in wild snakes with SFD, as well as experimentally affected snakes (Last et al., 
2016; Lorch et al., 2016; McCoy et al., 2017). However, this hypothesis is contradicted by other 
work that shows no change in weight despite progressing disease (Guthrie et al., 2016; Picquet et 
al., 2018).  Another hypothesis suggested that SFD infection leads to “risky” behaviors that 
expose the generally elusive snakes to environmental or predatorial threats (Lorch et al., 2016; 
Tetzlaff et al., 2017). One example the authors noted was an increase in heat-seeking behavior, 
whereby snakes are found basking during times when they are typically brumating in order to 
increase their body temperature to combat infection. This behavior increases their vulnerability 
to predation and environmental exposure (Lorch et al., 2016). Other hypotheses suggested that 
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systemic dissemination of O. ophiodiicola causes enough tissue damage to lead to host death 
(Vissiennon et al., 1999) or that death is due to the complications associated with secondary 
infections, such as bacterial infections (Lorch et al., 2016). While the exact mechanism or 
mechanisms of death have yet to be determined, it is possible  that the mechanism by which SFD 
causes individual disease and mortality is multifactorial.   
Influence of Host Factors on Disease Susceptibility 
 As previously mentioned, SFD is documented in a wide variety of species. While there is 
ongoing work aimed at determining if certain species are more susceptible or more-severely 
affected than others, it is important to note that risk factors and disease spread at the individual 
and population level are also influenced by environmental, behavioral, genotypic, and 
phenotypic factors (Burbrink et al., 2017). Simply put, snake species vary not only in their 
appearance, but also in their natural environment, genetic diversity, and various behavioral traits 
that likely contribute to disease susceptibility.  
 An important environmental factor to consider is both the macro- and microclimates in 
which an individual lives, and how those can impact susceptibility or resistance to various 
infections. Multiple hypotheses regarding this concept have been proposed. One such hypothesis 
is that changes in an individual's macroclimate, such as increased rainfall or alterations in 
temperature and humidity, and variations in soil microbiomes between wet and dry seasons may 
lead to changes in microbial communities that confer varying degrees of resistance to SFD 
(Allender et al., 2018). Conversely, cool and wet weather may increase prevalence and severity 
of fungal disease (Allender et al., 2015d; Lorch et al., 2016). Moist environments also facilitate 
O. ophiodiicola’s ability to grow and persist in the environment lending further support to this 
hypothesis (Lorch et al., 201
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time underground, therefore potentially increasing risk of exposure via burrowing through 
infected soil or by coming into closer contact with affected individuals in the same burrowing 
locations (Lorch et al., 2016). 
 Macro- and microclimate also influence snake behavior, host defense, and immune 
structure. As ectotherms, reptiles must modify their behavior relative to the season and 
temperature of their surrounding environment (Zimmerman et al., 2010). For example, reptiles 
are able to raise their body temperature via moving to warmer locations, or water, as well as 
basking in direct sunlight. While snakes are able to modify their behavior in such a way to 
compensate for environmental factors, there are physical changes that occur in colder 
temperatures that the individual cannot control. During colder temperatures, the frequency of 
molting decreases, allowing pathogens to persist on the skin for longer periods of time. 
Therefore, it is hypothesized that cool weather may increase the prevalence and severity of snake 
fungal disease (Allender et al., 2015d; Lorch et al., 2016).  
 In addition, during cold seasons, reptiles enter brumation to cope with extreme 
temperatures. During brumation, reptiles burrow in a suitable habitat where shifts in temperature, 
daylight, humidity, and hormonal changes trigger the individual's heart rate, respiration rate, and 
metabolism to slow down in order to conserve energy for the length of the cold season (Roman, 
2018). During brumation, involution of the thymus and white pulp of the spleen lead to 
decreased immune activity, possibly predisposing individuals to diseases that they would 
typically be able to fight off during their active states (Ridi et al., 1981 as cited in Zimmerman et 
al., 2010).  
 As previously stated, additional factors that influence host susceptibility to disease 
include both genotypic and phenotypic characteristics, including population size, habitat 
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destruction, concurrent disease, and loss of genetic diversity (Allender et al., 2017; Burbrink et 
al., 2017, Lorch et al., 2016). Small populations may be more affected by morbidity and 
mortality events because there is a relatively greater population impact when individual animals 
are lost (Lorch et al., 2016). Habitat destruction limits the area in which snakes can cohabitate, 
forcing snakes into closer proximity to one another, thereby increasing the chances of direct 
pathogen spread (Lorch et al., 2016). Second, habitat destruction leading to the direct loss of 
individuals contributes to smaller population sizes and therefore loss of genetic diversity due to 
inbreeding of remaining individuals (Allender et al., 2017; Burbrink et al., 2017, Lorch et al., 
2016).  
Reptilian Immune System 
 Although the reptilian immune system is vastly understudied, researchers have identified 
some of its key players. Similar to the mammalian immune system, both innate and adaptive 
immune responses have been identified in many reptilian species (Zimmerman et al., 2010. The 
skin and mucosal surfaces are the first lines of innate defense in reptiles (Origgi, 2007). Reptilian 
skin is often covered in a thick keratin layer that periodically sheds, providing protection against 
injury and superficial pathogens. If an organism is able to penetrate or evade these initial 
barriers, reptiles possess factors including transferrin, antimicrobial factors such as lysozymes 
and "defensin-like" molecules, and the complement system (Origgi, 2007; Zimmerman et al., 
2010). Reptiles also have white blood cells similar to their mammalian counterparts, including 
phagocytes (macrophages, and dendritic cells) as well as natural cytotoxic cells, monocytes, 
eosinophils, and basophils. Similar to mammals, these cells serve different roles in combatting 
different types of pathogens. Phagocytic cells, such as monocytes and macrophages, aid in 
antigen presentation and release cytokines that signal additional cells to the site of infection or 
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injury (Zimmerman et al., 2010). Heterophils, similar to mammalian neutrophils, are important 
in fighting off bacterial infections (Zimmerman et al., 2010). Reptilian basophils release 
histamine in response to an antigen-trigger.  
 In regard to adaptive immunity, both cell-mediated and humoral immunity have been 
documented in various reptilian species. Functional T cells, the key players in cell-mediated 
immunity that are responsible for the regulation of antibody production, have been identified in 
snakes, lizards, turtles, and tuatara (Burnham et al., 2005). This finding suggests that the reptilian 
immune system is capable of memory and has the ability to generate rapid immune responses to 
previously recognized antigens. B-cells, the key players in adaptive immunity and the subset of 
lymphocytes that is responsible for antibody (immunoglobulin) production, have also been 
identified in reptiles. However, whereas mammalian B cells produce 5 classes of 
immunoglobulins, reptiles are currently known to produce at least 2 classes: IgM and IgY 
(Natarajan, K et al., 1985). IgM is important in combatting Gram-negative bacteria as well as 
activating the complement system; however, it has a shorter half-life and is produced in small 
quantities. IgY has a longer half-life and can be produced in greater quantities; however, its 
specific function is not well-established (Zimmerman et al., 2010).  
 It is important to note that the reptilian immune system can also vary depending on 
numerous factors including habitat, life stage, reproductive status, thermoregulatory behavior, 
and season (Zimmerman et al., 2010). As in most animals, juveniles have a weaker immune 
system due to the fact that they are in the process of developing their adaptive immune response. 
Conversely, older individuals tend to have weaker immune responses due to a decrease in the 
number and function of immune cells. Reptiles in an active reproductive state, such as pregnant 
females, are also predisposed to certain infections given that their immune system is considered 
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to be in flux due to the presence of the fetus/fetuses. Given the complexity and seasonal variation 
in reptilian immunity, its study proves challenging and therefore the system as a whole remains 
poorly understood.     
Variability in Epidermal Structure Between Snake Species 
 Because SFD causes mild to severe disease in over 30 species of snakes (Franklinos et 
al., 2017; Lorch et al., 2016; Sigler et al., 2013), it is important not only to assess adaptations of 
this fungus, but also to understand the variability of disease presentation among species. 
Documentation of varying disease severities between species suggests that species-specific 
characteristics may also play a role in disease susceptibility and presentation (Guthrie et al., 
2016). 
 The study of reptilian skin structure and function proves to be a unique and difficult 
challenge to researchers. Not only does epidermal, dermal, and subcutaneous structure and 
function vary between snakes from different habitats, but structural characteristics can also vary 
within an individual depending on age, region of body, and season (Lillywhite et al., 2009; Shine 
et al., 2019). In a study comparing habitat type to skin thickness, the authors found that many, 
but not all, sea snakes had 50% thicker skin than their terrestrial and semi-aquatic species (Shine 
et al., 2019). However, on histologic examination, the authors determined that the epidermis was 
approximately the same thickness across the differing habitats, and that it was the deep dermis 
that was of increased thickness in sea snakes (Shine et al., 2019). These variations in dermal 
thickness and structure may play a role in the differences in susceptibility and severity of SFD 
infection between species.   
 Aquatic snakes have significantly less lipogenesis in the alpha keratinizing layer of the 
epidermis in compared to those of terrestrial snakes (Lillywhite et al., 2009), thereby increasing 
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water permeability. The epidermis is made up of four distinct layers: the outermost beta layer, 
the underlying mesos layer, the alpha keratinizing layer, and finally a single germinitive layer 
(Lillywhite et al., 2009). It is within this alpha-keratinizing layer that production of lipid occurs, 
which is thought to play a significant role in preventing transepidermal evaporative water loss by 
creating a hydrophobic barrier (Lillywhite et al., 2009). In aquatic snakes, it is possible that this 
decrease in lipogenesis within the epidermis relative to terrestrial species, and therefore a 
decreased hydrophobic barrier, may serve as a mechanism for increased susceptibility to 
cutaneous pathogens (Lillywhite et al., 2009). 
Diagnostic Testing 
 Currently, the best diagnostic test for detection of O. ophiodiicola is real-time 
quantitative polymerase chain reaction (qPCR) (Allender et al., 2015a; Bohuski et al., 2015) as it 
has a high degree of sensitivity and analytical specificity. This test specifically targets either the 
multi-copy internal transcribed spacer region (ITS) or intergenic spacer region (IGS) of O. 
ophiodiicola (Allender et al., 2015a; Bohuski et al., 2015). There are multiple advantages of this 
test including detection of as few as 10 copies of the fungal gene segment per reaction, allowing 
identification of the organism early in disease (Allender et al., 2015a). Using this qPCR assay on 
skin swabs allows for minimally invasive, rapid detection of fungal DNA presence (Allender et 
al., 2015b). Other methods of detection include traditional fungal culture and identification on 
histopathology (Bohuski et al., 2015); however, both of these methods have significant 
disadvantages. Traditional fungal culture may be difficult as there are numerous commensal 
fungi found naturally on reptile skin that may not be clinically significant (Bohuski et al., 2015; 
Allender et al., 2018). Other disadvantages include difficulty isolating the organism within small 
samples, unreliable identification based on morphological characteristics, and the slow-growing 
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nature of the organism leading to delayed identification (Bohuski et al., 2015). While histological 
identification of the organism within affected tissue may be helpful, various fungal organisms 
such as Fusarium sp., Geotrichum candidum, Sporothrix schenckii, Paecilomyces sp., and 
Pestalotia pezizoies (Barber et al., 2016) have fungal hyphae similar to that of O. ophiodiicola. 
The presence of arthroconidia distinguishes O. ophiodiicola from these other fungi, and therefore 
must be present to confirm a diagnosis of SFD histologically (Baker et al., 2019).  
Disease Control 
 There are few options for clinically managing SFD in affected snakes. Currently, most 
efforts are focused on rehabilitating individually affected snakes (Lindemann et al., 2017; Kane 
et al., 2017; Lorch et al., 2016) both with antifungal therapy and treatment of secondary and/or 
concurrent disease processes (Lindemann et al., 2017; Kane et al., 2017; Paré et al., 2016). In 
cases of severe dermatomycosis whereby there is extensive cutaneous or subcutaneous necrosis 
or proliferative lesions, debulking or debriding of these lesions has been used in attempt to allow 
systemic antifungal therapy to reach the affected areas (Paré et al., 2016).  
 Various antifungal therapies, including voriconazole, itraconazole, and terbinafine 
hydrochloride have been used in attempt to treat affected snakes; however, these have been 
variably successful thus far (Kane et al., 2016; Lindemann et al., 2017). Minimum inhibitory 
concentration (MIC) for itraconazole is 0.5-1 µg/mL for two O. ophiodiicola isolates and an 
MIC for voriconazole is 0.25 µg/mL for two O. ophiodiicola isolates (Kane et al., 2016). While 
both of these drugs were shown to be effective at killing O. ophiodiicola in culture, in vivo 
studies highlight their safety concern. In one study where six cottonmouths (Agkistrodon 
piscivorus) were administered 5 mg/kg of voriconazole via subcutaneous injection, three 
individuals died within 12 hours (Lindemann et al., 2017). The cause of these deaths was not 
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confirmed; however, seizure-like activity prior to death suggests neurotoxicity as the cause of 
death. In this same study, two Eastern massasaugas (Sistrurus catenatus) and one timber 
rattlesnake (Crotalus horridus horridus) diagnosed with SFD were treated with voriconazole via 
administration through implantable osmotic pumps; however, the authors noted that therapeutic 
plasma concentrations of voriconazole were not consistently reached (Lindemann et al., 2017). 
Lastly, these authors administered a single dose of itraconazole at 10 mg/kg via cloacal 
administration to seven apparently healthy free-ranging cottonmouths. Results showed that, 
again, tissue (kidney, liver, skin) and plasma concentrations of the itraconazole did not meet 
therapeutic concentrations based on in vitro data (Lindemann et al., 2017). Given these results, 
itraconazole and voriconazole are not currently considered safe or effective for use in snakes 
with SFD. 
 Terbinafine hydrochloride is also being studied for its potential use in the treatment of 
SFD. The MIC for terbinafine of 0.015 µg/mL for two O. ophiodiicola isolates (Kane et al., 
2016). Not only does this drug have the lowest MIC for combatting O. ophiodiicola in culture, 
but it has also been shown to reach therapeutic plasma levels in vitro via both nebulization and 
slow-release subcutaneous implantation (Kane et al., 2017). It is because of these desired effects 
that this drug is currently being studied as a non-invasive treatment method that can be used by 
both researchers and wildlife rehabilitation staff.  
Conclusion 
 The characterization of SFD, its impact on populations, and its pathogenesis have only 
fairly recently been studied. As an emerging fungal pathogen in snakes, great strides have been 
made to understand this organism’s structure and function (Allender et al., 2015d; Rajeev et al., 
2009; Sigler et al., 2013), geographic distribution (Allender et al., 2015d; Franklinos et al., 2017; 
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Lorch et al., 2016; Sigler et al., 2013), taxonomy (Burbrink et al., 2017), pathogenesis (Lorch et 
al., 2015), diagnostic testing (Allender et al., 2015a; Bohuski et al., 2015) and gross and 
histologic appearance of SFD (Baker et al., 2019). However, much remains unknown or poorly 
understood. To address some of these poorly understood areas, my study will focus on evaluating 
the presence of subclinical disease, correlating the presence of gross lesions with severity of 
cutaneous disease, correlating cutaneous and systemic disease, and documenting comorbidities 
that may impact disease susceptibility and/or severity in wild-caught Lake Erie water snakes. A 
better understanding of these factors and how they relate to one another will provide insight into 
subclinical manifestations of SFD, as well as aid in future sampling protocols for diagnostic 
testing.   
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CHAPTER 2: A STANDARDIZED APPROACH TO DETECTION AND SEVERITY OF 
CLINICAL AND SUBCLINICAL CUTANEOUS AND SYSTEMIC LESIONS IN LAKE 
ERIE WATERSNAKES NATURALLY INFECTED WITH OPHIDIOMYCES 
OPHIODIICOLA 
Abstract 
 Ophidiomyces ophiodiicola, the causative agent of ophidiomycosis (Snake Fungal 
Disease, SFD), is an emerging threat to both captive and free-ranging snake populations. 
Cutaneous lesions typify this disease process and can widely vary in presentation and severity. In 
this study, a standard protocol was developed using 23 wild-caught Lake Erie watersnakes to 
assess six hypotheses aimed at identifying pathologic characteristics, including disease severity 
and co-morbidities, of this often-fatal disease. SFD-associated cutaneous and visceral lesions 
were documented and characterized via gross examination and through histopathologic 
evaluation of 12 standardized skin survey sections using a novel histologic grading scheme. 
There was a positive relationship between the number of survey sections and overall cutaneous 
severity score. Subclinical lesions (n=117) were more prevalent than expected and were found in 
45.3% of all examined survey sections, including sections that were histologically graded as 
severe. The presence of visceral granulomas was not associated with overall cutaneous severity. 
The most prevalent comorbidity was absence of visceral adipose tissue; however, this was not 
associated with severity. Other comorbidities included verminous pneumonia, heterophilic 
enteritis and splenitis, cutaneous mites, and coccidiosis. This study provides in-depth 
documentation of both gross and histologic lesions associated with SFD and provides researchers 
and pathologists a process to evaluate cutaneous severity of disease in individuals with clinical 
(grossly visible) and subclinical (grossly absent) disease. 
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Introduction 
 Ophidiomyces ophiodiicola, the causative agent of ophidiomycosis (Snake Fungal 
Disease; SFD), is an emerging fungal pathogen causing morbidity and mortality in both wild and 
captive snakes (Allender et al., 2015d). SFD has been documented in terrestrial and aquatic 
snake populations in the United Kingdom, Germany, Australia, and North America (Franklinos 
et al., 2017; Lorch et al., 2016; Sigler et al., 2013). The most common presenting clinical signs of 
SFD infection include severe dermatitis, facial swelling, and emaciation (Lorch et al., 2016). It 
was previously thought that lesions associated with SFD were limited to the skin of the head and 
neck (Allender et al., 2011); however, recent reports have documented SFD skin lesions 
throughout many regions of the body (Chandler et al., 2019; Guthrie et al., 2016; Tetzlaff et al., 
2015). Rarely, lesions within the lungs, spleen, liver, eye, and kidneys have also been 
documented (Robertson et al.; Dolinski et al., 2014; Baker et al., 2019). SFD can be fatal; 
however, the mechanisms that lead to mortality, particularly concerning the pathology and role 
of comorbidities, are poorly understood. Additionally, a current lack of standardized pathologic 
assessment and histologic characterization of a wide range of SFD-associated lesions suggests 
that SFD may be underdiagnosed in both wild and captive populations. This information is 
particularly important for species that are endangered or threatened.   
 The aim of this study is to gain insight into the cutaneous disease severity, subclinical 
manifestation, systemic involvement, and comorbidities associated with SFD testing the 
following hypotheses: 1) the systematic mapping protocol derived from this methodology will 
identify characteristic lesions of SFD in a cohort of wild-caught Lake Erie water snakes, 2) as the 
number of survey sections affected by SFD increases, so too will the overall cutaneous severity 
score, 3) histopathological examination will allow for detection of subclinical lesions that are not 
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associated with gross disease, 4) individuals with visceral granulomas will have more severe 
cutaneous disease, 5) there will be a range of infectious and non-infectious conditions associated 
with ophidiomycosis, and finally 6) individuals with decreased visceral adipose tissue will have a 
higher overall cutaneous severity score as well as head cutaneous severity score than those with 
adequate visceral adipose tissue.   
Materials and Methods 
Study Population. Twenty-three individual, wild-caught Lake Erie water snakes (Nerodia 
sipedon insularun), consisting of 14 females and nine males, were sampled from an ongoing 
research study investigating novel SFD treatments. Nine of these snakes received terbinafine 
nebulization, five received saline nebulization, and nine did not receive any treatment. qPCR of 
full body swabs confirmed presence of Ophidiomyces during ante-mortem (n=19) or post-
mortem (n=4) exam. All snakes in this study were either found dead or euthanized due to disease 
and were submitted for necropsy examination (Table 2.1).  
External Exam, Diagnostic Necropsy, and Sample Collection. Measurements were taken from 
the tip of the snout to the tip of the tail, the tip of the snout to the cloaca, and the base of the skull 
to the cloaca. Each snake was linearized and nine equal sections (survey sections) were identified 
from the base of the head to the cloaca (Figure 2.1). Next, each cutaneous lesion, defined as any 
gross abnormality in scale appearance including hyperkeratosis, roughening, missing scales, scar 
formation, or retained shed as previously defined in Baker et al. (2019) was documented. Each 
lesion was assigned a unique identifying letter code, section associated with the lesion was 
recorded, diameter of the lesion was measured, gross description was recorded, and each lesion 
was photographed.  
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 The animal was incised along the ventral midline. Any subcutaneous nodules present 
were documented in the same format described for cutaneous lesions. Gross internal 
abnormalities, sex, and body condition (presence/absence of fat reserves) were recorded. 
Individuals with grossly visible visceral adipose bodies were classified as having "adequate" 
visceral adipose, and those without grossly visible adipose were classified as having "minimal" 
visceral adipose (Figure 2.2). Fresh samples of the lung, liver, kidney, gastrointestinal tract, and 
adipose tissue (if identified) were harvested and frozen at -80 °C. Full thickness, circumferential 
sections of the cloaca, tail, and the nine survey sections throughout the body were collected and 
fixed with 10% neutral-buffered formalin (Figure 2.3). Additionally, the entire head and sections 
of all viscera were collected and fixed with 10% neutral-buffered formalin.  
Histopathologic Evaluation and Case Definition. Formalin fixed tissues were routinely 
processed and embedded, and 5 μm sections were cut, mounted on glass slides, and stained with 
routine hematoxylin and eosin (H&E). Using histopathologic findings including presence or 
absence of fungal hyphae and/or arthroconidia, along with Ophidiomyces PCR testing (see 
Molecular Testing), each individual snake was assigned a classification of “confirmed”, 
“apparent”, “possible”, or “present” in accordance with the previously published case definition 
(Baker et al., 2019; Table 2.2). 
Individual Cutaneous Lesion Classification and Cutaneous Lesion Severity Scoring. Lesions 
were classified as “clinical” if both macroscopic and microscopic evidence of disease were 
observed within the survey section. Lesions were classified as “subclinical” if only microscopic 
evidence of disease was present. Each section was examined histopathologically and assigned a 
histologic grade (that correlated with increasing histologic lesion severity) based on a previously 
published grading scheme (McKenzie et al., 2019) (Table 2.3). Briefly, histologic features were 
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graded as follows: Grade 1 cutaneous severity lesions were characterized by low numbers of 
heterophils within the epidermis (Figure 2.4A); Grade 2 lesions included mild hyperkeratosis 
(Figure 2.4B), mild to marked serocellular crusts containing fungal organisms overlying the 
epidermis, heterophilic epidermitis, heterophilic, granulomatous, and/or lymphoplasmacytic 
dermatitis, and/or distinct dermal granuloma formation (Figures 2.4C, 2.4D, and 2.4E); and 
Grade 3 lesions had at least two of the following: severe epidermal ulceration and serocellular 
crusts containing fungal organisms (Figure 2.4F), extensive coagulative necrosis of the 
epidermis, dermis, subcutis, and skeletal muscle (Figures 2.4F and 2.4G), effacement of bone, 
and/or evidence of bony remodeling (Figures 2.4G and 2.4H), and inflammation extending into 
the bone marrow spaces (Figure 2.4I). The cutaneous severity grades of the 12 locations were 
summed for each snake to give a single overall severity score. The maximum overall cutaneous 
severity grade was 36 (i.e. if all 12 sections had a grade 3 severity).  
Molecular Testing. DNA was extracted from the tissues (DNeasy kit, Qiagen, Valencia, CA) and 
skin swab samples using commercial kits (DNA Blood Mini Kit, Qiagen, Valenica, CA). The 
DNA extracts from skin and internal organs were assayed for Ophidiomyces using qPCR 
(Allender et al., 2015b) and pan–herpesvirus using conventional PCR (VanDevanter et al., 
1996). 
Statistical Analysis. Statistical analysis was performed to test the six established hypotheses. 
Prevalence proportion of snakes in each disease category, sex, and species were tabulated for 
both clinical and subclinical disease. Pearson’s correlation was used to determine the relationship 
between number of sections affected by SFD and the overall cutaneous severity score. Histologic 
grade was compared between gross lesion types (e.g. crust, thick scale, raised scale, ulcer, and 
necrosis) using a Kruskal-Wallis test. The total number of segments with subclinical disease was 
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compared between snakes that received terbinafine treatment and those that either received saline 
nebulization or no treatment using a Mann-Whitney U. A Mann-Whitney U Test was also used 
to compare overall, head, tail, and cloacal severity between individuals with and without visceral 
granulomas. Similarly, a Mann-Whitney U test was used to compare the overall cutaneous 
severity scores between individuals with varying amount of visceral adipose tissue stores. 
Comorbidities were described qualitatively and tabulated. All comparisons were calculated using 
R statistical software (R core team, 2019). Statistical significance was considered for all p values 
£ 0.05. 
Results 
Hypothesis 1: Systematic mapping protocol derived from this methodology will identify 
characteristic gross and histologic lesions of SFD in a cohort of wild-caught Lake Erie 
watersnakes.  
 Gross evidence of cutaneous ophidiomycosis was identified in each of the 9 survey 
sections of the body, as well as the head, tail, and cloaca of at least one snake. Evidence of SFD 
was not found along the oral or cloacal mucous membranes. Several gross lesion types were 
observed, including brown friable crusts, raised scales, thickened scales, ulceration, granuloma 
formation, and necrosis (Figure 2.5A-F, Table 2.4). Crusts were identified throughout each of the 
12 survey locations (i.e. there was no location that didn't have at least 1 snake with an SFD-
associated lesion at that location). Raised scales were present in each of the survey locations, 
except the head and cloaca, of at least one snake. Thickened scales were identified in the head, 
tail, and body survey section locations 2, 3, 4, 5, and 8 of at least one snake. Gross evidence of 
ulceration, defined as complete loss of scales/epidermis that expose underlying dermis or deeper 
tissues, was identified in a single snake in body survey section 4; a granuloma was identified in 
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the head of a single individual; and gross evidence of necrosis, defined as a single or multiple 
scales that was elevated or misaligned, discolored, and sloughed when light pressure was applied 
(Baker et al., 2019), was identified in the tail of 2 individuals (Table 2.5). Grossly evident 
necrosis (median=3) had the most severe histologic grade, followed by displaced/thickened scale 
(median=2), crust (median=2), and none (median=1) (p<0.0001). 
 A total of 276 survey sections were examined (23 snakes, 12 survey sections per 
individual). There were 258/276 (93.5%) survey sections that had evidence of SFD-associated 
lesions ranging from histologic grade 1-3 (Table 2.6). All 23 snakes had histologic evidence of 
ophidiomycosis in the head as well as at least one lesion within the cranial, middle, and caudal 
one-third of the body. Twenty-one (91%) snakes had evidence of ophidiomycosis in the cloaca, 
and 20 (87%) snakes had evidence of ophidiomycosis in the tail (Table 2.7). The median 
histologic grade for lesions of the head was a grade 3. The median histologic grade for lesions of 
the tail was a grade 2. The median histologic grade for all remaining survey sections (all 9 body 
sections and cloaca) was a grade 1 (Table 2.8). 
 The study population consisted of eight snakes that received terbinafine nebulization 
treatment for different lengths of time, six that received saline nebulization as a control, and nine 
that did not receive any form of treatment. Snakes that were treated with terbinafine nebulization 
had a significantly lower overall histologic cutaneous severity score (median= 13) than those that 
either received saline nebulization or no treatment at all (median=19) (p=0.022, W=24).   
Hypothesis 2: As the number of survey sections affected by SFD increases, so too will the 
overall histologic cutaneous severity score. 
 The total number of sections affected by SFD-associated lesions for each snake ranged 
from 8-12 (median = 12). Cutaneous severity scores in an individual snake ranged from 9 to 31 
 
 
25 
(median = 16) (Table 2.9). There was a significant positive correlation between the total number 
of survey sections with histologic evidence of ophidiomycosis and the cutaneous severity (Table 
2.10). Furthermore, histologic grade of survey sections 1, 3, and 7 showed the greatest 
correlation with overall cutaneous severity (r = 0.869, 0.742, and 0.744 respectively).  
Hypothesis 3: Histopathological examination will allow for detection of subclinical lesions 
that are not associated with gross disease  
 Subclinical disease was identified in 117 out of 258 survey sections with lesions of SFD 
(45.3%). Histologic grades ranged from grade 1 to grade 3 in subclinical lesions. Clinical disease 
was identified in 141 out of 258 survey sections with lesions of SFD (54.7%). Histologic grades 
of clinical lesions ranged from grade 0 to grade 3. The three sections (out of 258 total sections 
with lesions of SFD) that were classified as a grade 0 were identified as having a grossly 
identifiable cutaneous lesion, but no evidence of microscopic SFD-associated disease.Therefore, 
these lesions were interpreted as unassociated with SFD. In 18/276 (6.5%) total survey sections, 
there was no evidence of microscopic or gross SFD-associated lesions (Table 2.11).   
 Snakes that were treated with terbinafine nebulization had a median of six survey 
sections that were affected by subclinical disease. Snakes that did not receive treatment or 
received saline nebulization had a median number of five survey sections that were affected by 
subclinical disease. There was no significant difference in the prevalence of subclinical disease 
between snakes treated with terbinafine nebulization and those that either received saline 
nebulization or no treatment at all (p=0.922, W=58).   
 Following gross, histopathologic, and molecular evaluation, 16 (of 23) snakes were 
diagnosed with confirmed ophidiomycosis, three were classified as apparent ophidiomycosis, 
and four were classified as possible ophidiomycosis (Table 2.2). 
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Hypothesis 4: Individuals with visceral granulomas will have more severe cutaneous disease, 
as well as a higher median head, tail, and cloaca severity score than those without visceral 
granulomas. 
 Subcutaneous granulomas were identified in three (13%) watersnakes. Only one had 
characteristic fungal hyphae of O. ophiodiicola within the center of the subcutaneous 
granulomas.   
 Visceral granulomas were histologically identified in 8/23 individuals and were 
associated with the respiratory system (trachea, lung), gastrointestinal tract (esophagus, stomach, 
liver), urinary system (kidney), and hematopoietic (spleen) system. Of the eight individuals with 
visceral granulomas, overall cutaneous severity scores ranged from 11-23. Only two of the 
snakes demonstrated characteristic O. ophiodiicola hyphae within the center of the visceral 
granulomas, neither of which had subcutaneous granulomas containing intralesional 
characteristic O. ophiodiicola hyphae. Snakes with visceral lesions had no more severe 
cutaneous infections than those without visceral involvement (p = 0.234). Additionally, snakes 
with visceral lesions did not have more severe cloacal, tail, or head infections than those without 
visceral involvement (p = 0.516, 0.897, 0.347 respectively).   
Hypothesis 5: There will be a range of infectious and non-infectious conditions in snakes with 
ophidiomycosis. 
 Comorbid skin conditions were documented in all 23 snakes (100%). Comorbidities of 
the skin included concurrent bacterial infection (100%), algal infection (4%), and cutaneous mite 
presence (22%). Intraluminal nematodes without inflammation were observed in both the 
respiratory (78.3%) and gastrointestinal tract (56.5%). Comorbid conditions were found less 
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frequently within the liver, splenopancreas, esophagus, trachea, central nervous system, heart, 
kidneys, reproductive tract, and subcutis (Tables 2.12 and 2.13).  
Hypothesis 6: Individuals with decreased visceral adipose tissue will have a higher overall 
cutaneous severity score as well as head cutaneous severity score than those with adequate 
visceral adipose tissue.  
 Marked reduction in visceral adipose tissue stores was common, as visceral adipose 
tissue was not grossly visible in 19 of the examined snakes (82.6%). There were no significant 
differences in the severity of head lesions between snakes with adequate visceral adipose tissue 
(n=4) and those with minimal visceral adipose tissue (n=19) (p=0.075, W=58). There was no 
significant difference in the overall cutaneous severity between snakes with adequate adipose 
tissue (n=4) and those with minimal visceral adipose tissue (n=19) (p=0.745, W= 42). 
Discussion 
 Using our standardized sampling system of surveying circumferential skin sections 
throughout 12 standardized body sections of each individual, a wide range of SFD-associated 
lesions were documented that are consistent with previous studies (Allender et al., 2011; Baker et 
al., 2019; Lorch et al., 2016). Gross lesions of necrosis had the highest histologic grade, which is 
consistent with known pathogenesis (Baker et al., 2019) and signifies the most severe lesion 
type. All areas of the body are susceptible to SFD, as demonstrated by the presence of SFD-
associated lesions in all survey section locations. Out of the 12 survey locations, the head was 
consistently the most severely affected and had the fewest subclinical lesions. Early reports of 
SFD were mainly associated with lesions of the head (Allender et al., 2011); thus, it is reasonable 
to assume that initial observations of this disease were diagnosed based solely on the most 
severe, grossly visible lesions of the head (Lorch et al., 2016). Because the head appears to be 
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the most commonly and most severely affected, the head is a good location to inspect and sample 
to identify the presence or absence of disease. Additionally, it seems like subclinical lesions are 
unlikely in the head either due to anatomic differences or possibly due to higher exposure to 
fungal quantity. Future studies should investigate how location of initial infection and fungal 
quantity affect disease progression. 
 It is important to note that histologic lesions of varying severity were often present within 
the same individual. This finding is likely attributable to multiple factors including cutaneous 
bacterial coinfection, chronicity of lesion, and predisposing lesions such as trauma. In all 23 
snakes, at least one cutaneous lesion per individual that was attributed to SFD also had 
concurrent intralesional bacterial organisms. The secondary infection likely complicates the 
snake’s ability to resolve the ongoing infection. Additionally, individual snakes had multiple 
cutaneous histologic lesions that differed in their inflammatory cell components. For example, 
multiple individuals had survey sections that exhibited predominantly a dermal macrophage 
infiltrate as well as formation of discrete, dermal granulomas without epidermal inflammation, 
ulceration, or crusting, suggesting a more chronic cutaneous lesion that would be classified as a 
grade 1 histologic severity. In these same individuals, other survey sections showed a 
predominantly heterophilic epidermal and dermal cellular infiltrate with prominent epidermal 
ulceration and crusting, which suggests an acute or ongoing inflammatory process that would be 
classified as a grade 2 histologic severity. It is possible that this variation in cutaneous severity 
may represent a spectrum of early and late stages of disease where lesions are in various phases 
of resolution. Lastly, previous studies suggest that a break in the epidermis facilitates fungal 
invasion of the site (Allender et al., 2015a; Lorch et al., 2015). In this study, it is possible that 
more severe cutaneous lesions represent previous sites of trauma or excoriation that facilitated a 
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more severe infection. Given that these were wild-caught animals, and therefore without known 
clinical history, previous damage to the epidermis can only be speculated and further 
investigation using an experimental design would be necessary to further tests this hypothesis.  
 Results of this study show, unsurprisingly, that as the number of survey sections affected 
by SFD-associated lesions increases, the overall cutaneous severity increases as well. This 
relationship indicates that a wide distribution in lesion location is indicative of more severe 
overall cutaneous disease. The increasing histologic grade of survey sections 1, 3, and 7 is 
strongly associated with increasing overall number of sections affected by SFD. Therefore, 
during clinical or necropsy examination, ensuring that these three survey locations are examined 
for SFD-associated lesions will be beneficial in determining whether or not the individual has 
severe cutaneous disease. This information directs those performing necropsies on snakes with 
potential SFD to be able to extrapolate as much information regarding the snake’s overall 
cutaneous disease without needing to histologically examine numerous samples.  
 One of the limitations of this study was that the sample population used wild-caught 
individuals with severe cutaneous SFD of unknown duration. Therefore, these conclusions may 
not hold true when evaluating less severely affected individuals. Additionally, this study 
population was composed of a single species. Previous studies suggest that there are species-
specific factors, such as skin structure, habitat, and genotypic and phenotypic diversity that play 
a role in disease susceptibility and presentation (Burbrink et al., 2017; Guthrie et al., 2016; Shine 
et al., 2019). Thus, future studies using this method should investigate different species and/or 
natural habitats in snakes with a full spectrum of disease, ranging from mild to severe, in order to 
evaluate the effects of these various factors on this study’s conclusions.  
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 Currently, few studies have documented and characterized subclinical disease (Allender 
et al., 2015a; Lorch et al., 2015); however, many studies solely focus on grossly visible lesions 
and tend to describe severe infections associated with SFD (Guthrie et al., 2016; Last et al., 
2016; Ohkura et al., 2016). Subclinical disease may represent early or resolving O. ophiodiicola 
infection, as many of these lesions had minimal heterophilic inflammation, suggesting acute 
inflammation, or had well-defined regions of granulomatous inflammation, suggesting late stage 
or chronic infection. Documentation and characterization of subclinical lesions is crucial in 
identifying cases of SFD, characterizing the epidemiology, and implementing successful 
treatment strategies. Additionally, characterization of subclinical lesions will help researchers 
and rehabilitators to monitor resolution of SFD infection. It should be noted that there was no 
significant difference in subclinical disease prevalence between treated and non-treated snakes; 
therefore, it is possible that current treatment methods may not adequately rid snakes of 
subclinical lesions.  
 In this study, 45.3% of SFD-associated lesions identified were identified by 
histopathology alone and did not show evidence of gross lesions. The current case definition 
emphasizes the use of a combination of Ophidiomyces PCR/fungal culture, gross SFD-associated 
lesions, and histologic evidence of SFD-associated lesions along with identification of the fungal 
organism and morphology in confirming the diagnosis of ophidiomycosis (Baker et al. 2019). In 
this study, not only were subclinical SFD-associated lesions identified, but they happened with 
such frequency that it calls into question the utility of the current case definition. It is reasonable 
to conclude that histopathology using circumferential sampling is more appropriate than using 
gross lesions alone to identify confirmed ophidiomycosis. However, this circumferential 
sampling is impractical in live snakes. Therefore, future studies using smaller survey samples is 
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warranted to see if this result holds true. There were also low numbers of grossly visible SFD-
like lesions that were documented without microscopic evidence of SFD. This finding indicates 
that gross lesions that are typically attributed to SFD may sometimes be representative of other 
disease processes, such as previous trauma, bacterial infection, or to fungal infections other than 
O. ophiodiicola, such as Fusarium sp., Geotrichum candidum, Sporothrix schenckii, 
Paecilomyces sp., or Pestalotia pezizoies (Barber et al., 2016). It is also possible that the highly 
focal nature of this disease failed to include the characteristic lesions of SFD in the plane of 
section evaluated. Therefore, in snakes with suspicious lesions, it is crucial to histologically 
examine multiple sections, as evaluation of a single plane of section may fail to identify SFD-
associated lesions that are actually present.  
 The vast majority of subclinical lesions, and even those lesions that were grossly visible, 
did not have microscopic evidence of the fungal organism. All snakes in this study were 
confirmed to be qPCR-positive for O. ophiodiicola; however, this result was based on a full body 
swab, not swabs from each individual survey section. Therefore, although lesions were classified 
as “SFD-associated” according to the current case definition (Baker et al., 2019), it would be 
necessary to run qPCR and histopathology for O. ophiodiicola on each sample to confirm the 
lesions are directly associated with the presence of O. ophiodiicola. It also illustrates the 
importance of considering SFD in animals without histologically visible fungal organisms.  
 The pathogenesis of systemic infection by O. ophiodiicola has not been established and 
there is a paucity of information associating cutaneous disease severity and systemic disease. In 
this current study population, snakes with visceral granulomas did not have more severe 
cutaneous disease. This finding suggests that either severe cutaneous infection is not associated 
with systemic visceral granuloma formation, or that visceral granulomas are not due to O. 
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ophiodiicola infection. While fungal organisms within visceral granulomas were identified in 
only two snakes, it is possible that other organisms such as Mycobacteria sp. or other bacteria 
were the underlying cause of these visceral granulomas. It is also possible that intralesional 
fungal organisms within granulomas were not included in the plane of section that was 
evaluated, which highlights the limitation in using only histopathology for diagnosis. If these 
granulomas are, in fact, due to O. ophiodiicola infection, there are a number of confounding 
factors that may have resulted in falsely concluding that there is a lack of correlation between 
cutaneous severity of infection and visceral granulomas formation. Two confounding factors 
present in this study include duration of infection and treatment effect. For example, individuals 
in this study that were treated with terbinafine nebulization tended to have lower overall 
cutaneous severity scores than those that were not treated or that received saline nebulization as a 
control. Thus, this confounding variable of treatment may have contributed to an overall 
decrease in median cutaneous severity in snakes with visceral granulomas when comparing these 
scores between snakes with and without visceral granulomas. It remains unclear how visceral 
granulomas relate, if at all, to disease severity. Although this study’s results suggest that there is 
no correlation between cutaneous severity and visceral granuloma formation, anecdotal evidence 
suggests that systemic dissemination, or visceral granuloma formation, may be a consequence of 
fungemia secondary to severe cutaneous infection.  
 Severe cutaneous infection may lead to fungemia and secondary systemic dissemination. 
In this study, fungal organisms were not identified within the vasculature, nor was there evidence 
of a vasculitis. However, given the variability in sample surveillance as well as section of cut of 
histologic sections, this observation does not completely rule out fungemia as a potential 
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mechanism of spread. Further studies, such as blood culture, may be necessary to lend further 
support to this proposed pathogenesis.  
 The most common comorbidity found within our study population was a marked 
reduction in visceral adipose tissue. This finding is consistent with previous reports of severe 
emaciation and starvation in cases of snakes with severe fungal disease (Lorch et al., 2016). It is 
hypothesized that in these cases, severe infection of the head could alter the individual's vision 
and olfactory sensation thereby inhibiting its ability to hunt prey (Lorch et al., 2016). There was 
no difference in the histologic severity of the head in Lake Erie water snakes between the snakes 
with adequate versus decreased visceral adipose tissue, suggesting SFD-associated head lesions 
do not contribute to a snake's ability to maintain adequate fat reserves. Alternatively, it is 
possible that decreased visceral adipose tissue stores are associated with an increase in resting 
metabolic rate as observed in pygmy rattlesnakes (Sistrurus miliarius) (Agugliaro et al., 2019). A 
decrease in adipose stores may be mediated through a stress response in which energetic priority 
is given to essential life-preserving functions, such as an increase in cortisol, glucagon, and 
catecholamines (Ndahimana et al., 2018), or to mount an immune response (Agugliaro et al., 
2019; Hawley et al., 2012; Otalora-Ardila et al., 2016). Production of phagocytes, synthesis of 
immunoglobulins, production of components of the complement system, production of numerous 
intracellular enzymes, and production of proteins are dependent upon adequate cellular energy 
(Beisel, 1975). Therefore, it is unsurprising that the energetic resources of SFD-affected snakes 
are being used to combat infection and thus are consuming any visceral fat stores in the process.  
 While a direct link has not been established between specific comorbidities and severity 
of SFD, many snakes within this study population had comorbidities of both infectious and non-
infectious etiologies. Within the vast majority of the snakes examined, comorbidities were 
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considered incidental and did not appear to incite a significant inflammatory response to suggest 
contribution to the animal’s demise. Further investigation into the specific comorbidities is 
necessary to understand disease pathogenesis and their contribution to the animal's overall health 
status. However, this study shows that it is likely that SFD alone can lead to individual mortality.  
 The exact mechanism by which SFD causes mortality is unknown. As previously 
mentioned, many affected snakes have decreased visceral adipose tissue stores, and many reports 
describe severe emaciation associated with disease (Lorch et al., 2016; McCoy et al., 2017). It is 
possible that snakes with SFD, whether with severe cutaneous disease or persistent low-grade 
chronic infection (i.e. those with low overall cutaneous severity grades), are in a constant state of 
negative energy balance that ultimately leads to decline of the host’s condition and death 
(Agugliaro et al., 2019). However, the true mechanism leading to mortality is not clear from this 
or any other study and should remain a focus of future research. 
 This study provided in-depth documentation of both gross and histologic lesions 
currently associated with SFD and highlighted the importance of combining fungal PCR/culture, 
gross and histologic examination to accurately assess the SFD infection status of individual 
snakes. In particular, this study found that subclinical lesions are nearly as common as cutaneous 
gross lesions. This information is important for researchers and rehabilitators to be aware of, as 
gross examination alone cannot rule out O. ophiodiicola infection or confirm clearance of O. 
ophiodiicola in treated individuals, and may in fact miss significant SFD lesions. In the same 
regard, negative O. ophiodiicola PCR of cutaneous swabs should be interpreted with caution, as 
subepidermal or visceral presence of O. ophiodiicola can be missed.  
 This study found that, in this species, the head is often the most severely affected portion 
of the snake, although subclinical lesions were rarely documented in the head. Because there will 
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likely be gross lesions if the head is affected by SFD (and thus histology might not be needed for 
detection of disease in these animals), the head is a poor site for surveillance in animals without 
cutaneous gross lesions. For more in-depth information on the overall cutaneous severity of 
disease in an individual, this study shows that the best samples to take include those from survey 
sections 1, 3, and 7 as the severity in these sections corresponds to overall severity of disease. 
 Future directions include using this survey method in various snake species including 
those that differ in natural habitat and location. This information would be beneficial in 
determining if there is a particular section of the animal that is consistently affected by gross 
cutaneous or subclinical disease. Secondly, use of this survey method would be beneficial in 
studies that evaluate response to treatment as this method does not solely rely on gross lesions as 
an indicator of disease. In particular, biopsy examination of survey sections may be helpful in 
tracking not only treatment response, but could also be used in tracking disease progression as 
lesions progress or regress over time.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
36 
TABLES AND FIGURES 
 
 
Figure 2.1. Eastern massasauga rattlesnake (Sistrurus catenatus). Twelve survey sections were sampled as part of a standardized gross 
and histopathologic evaluation.  
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Figure 2.2. Adequate (A) and minimal (B) visceral adipose tissue surrounding intestines in Lake Erie watersnakes (Nerodia sipedon 
insularum). 
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Figure 2.3. Full-thickness, circumferential section of a body survey section to be evaluated histologically.  
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Figure 2.4. Gross lesions associated with SFD in Lake Erie watersnakes (Nerodia sipedone insularum). A) Grade 1 cutaneous 
severity: heterophilic inflammation limited to the epidermis (arrows), mild hyperkeratosis (*), B)  Grade 2 cutaneous severity: mixed 
inflammation extending into the dermis (arrow), mild hyperkeratosis (arrow head), extensive serocellular crusting (*). C) Grade 2 
cutaneous severity: granulomatous inflammation limited to the dermis, discrete granuloma (*). D) Grade 2 cutaneous severity: 
granulomatous and heterophilic inflammation with multiple discrete granulomas (*). E) Grade 2 cutaneous severity: heterophilic 
epidermitis with dermal granuloma formation. F) Cross section of tail, Grade 3 cutaneous severity: epidermal ulceration and fungal 
crusts with coagulative necrosis of the epidermis, dermis, subcutis, and skeletal muscle. G) Longitudinal section of rostral maxilla, 
Grade 3 cutaneous severity: coagulative necrosis of the rostrum effacing regions of bone (box). H) Higher magnification of "G" 
showing bony changes: irregularly scalloped cancellous bone with numerous osteoblasts and fewer osteoclasts (arrows). I) Grade 3 
cutaneous severity: heterophilic and granulomatous inflammation within the bone marrow space. 
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Figure 2.4 (continued). 
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Figure 2.5. Gross lesions associated with SFD in Lake Erie watersnakes (Nerodia sipedon insularum). A) Multifocal crusts, B) Cluster 
of raised scales, C) Thickened scales (yellow arrow), D) Focal ulceration, E) Necrosis, F) Maxillary granuloma causing facial 
distortion. 
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Table 2.1. Summary of demographic variables for 23 Lake Erie water snakes (Nerodia sipedon insularum). 
 
 
 
1 SVL indicated snout to vent (cloaca) length 
2 # of treatment months indicates total number of months the individual received terbinafine nebulization treatment.  
ID Sex Age 
Class 
Weight 
(g) 
SVL 
(cm)1 
Died/Euthanized # of Treatment 
Months2 
SFD Ante/Post-Mortem 
PCR 
Days in 
Captivity 
18-132 Female Adult 322.53 84.5 Died 0 + 9 
18-133 Female Adult 371.42 91 Died 0 + 0 
18-134 Female Adult 298.00 86 Died 0 + 0 
18-135 Male Adult 149.14 72 Died 0 + 0 
18-136 Female Adult 285.56 84 Euthanized 0 + 0 
 
18-137 Male Adult 119.24 62 Euthanized 0 + 21 
18-146 Male Adult 92.11 59.5 Died 0 + 35 
18-147 Male Adult 99.74 61 Died 0 + 32 
18-148 Male Adult 183.79 74 Died 0 + 31 
18-158 Female Adult 255.00 93.5 Died 0.5 + 50 
19-10 Male Adult 157.88 72.5 Died Saline Control + 79 
19-11 Female Adult 270.46 85.5 Died Saline Control + 69 
19-12 Female Adult 220.94 81.5 Died Saline Control + 60 
19-13 Female Adult 290.50 88.5 Died 1 + 69 
19-14 Male Adult 130.00 67 Died 1.5 + 74 
19-15 Male Adult 139.06 71 Euthanized 1.5 + 135 
19-16 Male Adult 161.58 68 Died 2 + 106 
19-17 Female Adult 303.81 92 Died Saline Control + 104 
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Table 2.1 (continued) 
ID Sex Age 
Class 
Weight 
(g) 
SVL 
(cm) 
Died/Euthanized # of Treatment 
Months 
SFD Ante/Post-Mortem 
PCR 
Days in 
Captivity 
19-18 
19-19 
19-20 
Female 
Female 
Female 
Adult 
Adult 
Adult 
278.97 
258.69 
351.95 
87 
84 
90 
Euthanized 
Euthanized 
Died 
Saline Control 
3 
3 
+ 
+ 
+ 
162 
160 
166 
19-21 Female Adult 291.85 88 Euthanized 2 + 110 
19-22 Female Adult 208.60 87 Euthanized Saline Control + 208 
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Table 2.2. Ophidiomycosis classification scheme according to Baker et al. (2019). 
Classification O. ophiodiicola 
qPCR/Culture results 
Gross Lesions 
consistent with 
Ophidiomycosis 
Histologic Lesions 
consistent with 
Ophidiomycosis 
 
Ophidiomyces Present 
 
+ - - 
Possible 
Ophidiomycosis 
 
- + + 
Apparent 
Ophidiomycosis 
 
+ + + (hyphae, but NO 
arthroconidia) 
Confirmed 
Ophidiomycosis 
+ + + (arthroconidia 
present) 
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Table 2.3. Histopathologic grading scheme for histologic cutaneous lesions according to McKenzie et al. (2019). Each lesion is 
assigned to a histologic grade based on the total number of points. Grades are as follows: Grade 0 (0 total points), Grade 1 (0-3 total 
points), Grade 2 (4-5 total points), Grade 3 (6-8 total points).  
 
Feature Description Points 
Inflammation None 0 
 Heterophils in epidermis 1 
 Mixed inflammation, dermal involvement 2 
 Mixed inflammation, muscle involvement 3 
 
Necrosis None 0 
 Minimal 1 
 Coalescing areas, < 1 scale width 2 
 Coalescing areas, > 1 scale width 3 
 
Other Serocellular crust 1 
 Ulceration 1 
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Table 2.4. Presence of gross lesions in Lake Erie watersnakes (Nerodia sipedon insularum) within each individual and each survey 
section. 
Snake Head 1 2 3 4 5 6 7 8 9 Cloaca Tail 
             
18132 Crust Raised scale, 
crust 
None Raised 
scale 
None Crust Raised 
scale 
None None None None Necrotic 
18133 Thick scale None None Ulcer Thick 
scales 
Crust None None None None None None 
18134 Crust Crust Crust Crust Crust Crust Crust Crust Crust Crust Crust Crust 
18135 Thick scale None None None None None None Raised scale, 
crust 
None None None None 
18136 Thick scale, 
crust 
None Crust None None None Crust None None None None None 
18137 Crust, 
Granuloma 
None None None Raised 
scale 
None None None None None None None 
18146 Thick scale, 
crust 
Crust None Crust Raised 
scale 
Raised 
scale 
None None None None None None 
18147 Thick scale None None None None Raised 
scale 
None None Raised scale None None Crust 
18148 None None Thick 
scale 
Thick 
scale 
None None None None Thick scale None None Necrosis 
18158 Thick scale None None None None None None None None None None Thick 
1910 Raised, crusted 
scale 
None Raised 
scale 
None Crust Crust None Crust Crust None None Thick 
1911 Crust Crust Crust Crust Crust Crust Crust Crust Crust None None Crust 
1912 Crust None None None None None Crust Crust Crust None None None 
1913 None None None Thick 
scale 
None Thick 
scale 
None None None None None None 
1914 Crust Raised scale None None Raised 
scale 
Raised 
scale 
Raised 
scale 
Raised scale Raised scale Raised 
scale 
None Raised 
scale 
1915 Crust Crust None Thick 
scale 
None Thick 
scale 
None None None None None Crust 
1916 Crust Crust None None Raised 
scale 
None None None None Raised 
scale 
None None 
1917 Crust Crust Crust Crust Crust Crust Crust None Crust Crust None Crust 
1918 Crust Crust Crust Crust Crust None Crust Crust Crust Crust None Crust 
1919 Crust Crust None None None None None None Thick, raised 
scale 
Crust None Crust 
1920 Thick scale Raised scale None None None Crust Crust Crust None None None None 
1921 Crust Crust Crust Crust Crust None Crust None Raised scale Raised 
scale 
None Raised 
scale 
1922 None Crust Crust Crust None None None Crust None Crust Crust Crust 
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Table 2.5. Prevalence of each type of gross lesion present in twelve survey sections from 23 Lake Erie watersnakes (Nerodia sipedon 
insularum). 
 Crust Raised Scale Thickened Scale Ulcer Granuloma Necrosis 
Head 15 (65.2%) 0 7 (30.4%) 0 1 (4.3%) 0 
1 11 (47.8%) 3 (13%) 0 0 0 0 
2 7 (30.4%) 1 (4.3%) 1 (4.3%) 0 0 0 
3 7 (30.4%) 1 (4.3%) 3 (13%) 1 (4.3%) 0 0 
4 6 (26.1%) 4 (17.4%) 1 (4.3%) 0 0 0 
5 7 (30.4%) 3 (13%) 2 (8.7%) 0 0 0 
6 8 (34.8%) 2 (8.7%) 0 0 0 0 
7 8 (34.8%) 2 (8.7%) 0 0 0 0 
8 6 (26.1%) 4 (17.4%) 1 (4.3%) 0 0 0 
9 5 (21.7%) 3 (13%) 0 0 0 0 
Cloaca 2 (8.7%) 0 0 0 0 0 
Tail 8 (34.8%) 3 (13%) 2 (8.7%) 0 0 2 (8.7%) 
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Table 2.6. Histologic cutaneous severity score of each survey section for each individual Lake Erei watersnake (Nerodia sipedon 
insularum). 
 
Snake Head 1 2 3 4 5 6 7 8 9 Cloaca Tail 
18132 3 2 2 2 2 3 2 3 1 0 0 3 
18133 3 1 1 3 1 1 2 0 1 1 1 1 
18134 3 3 3 3 2 2 3 2 2 3 1 1 
18135 3 1 1 1 1 1 1 1 1 1 1 3 
18136 3 1 1 1 1 1 1 1 1 1 2 0 
18137 3 1 1 1 1 1 1 1 1 0 1 1 
18146 3 3 1 2 2 1 1 1 1 2 3 3 
18147 2 2 1 2 1 2 3 2 2 0 1 2 
18148 2 2 1 2 1 1 1 1 1 1 3 3 
18158 2 1 1 1 1 1 1 0 0 1 0 0 
199 0 0 0 1 0 0 0 0 1 1 1 2 
1910 2 1 2 2 2 1 2 1 2 2 1 2 
1911 3 3 3 3 2 2 3 2 2 2 3 3 
1912 2 1 1 1 1 1 2 1 2 1 1 1 
1913 1 1 1 1 1 1 0 0 1 1 1 1 
1914 3 2 1 1 2 2 1 2 2 2 2 2 
1915 3 1 1 0 1 0 1 1 1 0 1 2 
1916 3 1 0 0 1 1 1 0 1 1 2 0 
1917 3 2 0 2 1 2 2 2 1 1 3 2 
1918 1 2 2 1 2 2 1 1 1 1 1 1 
1919 2 1 1 1 1 1 1 0 2 1 1 3 
1920 3 1 1 1 1 1 1 1 1 1 1 1 
1921 2 2 1 2 1 1 1 1 2 2 2 2 
1922 1 1 1 2 1 1 1 1 1 1 1 2 
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Table 2.7. Prevalence of histologic lesions of SFD within 12 survey sections from 23 Lake Erie watersnakes (Nerodia sipedon 
insularum). 
 
Survey Section Number of snakes with histologic lesion in each section 
Head 23 (100%) 
1 23 (100%) 
2 21 (91.3%) 
3 21 (91.3%) 
4 23 (100%) 
5 22 (95.7%) 
6 22 (95.7%) 
7 18 (78.3%) 
8 22 (95.7%) 
9 19 (82.6%) 
Cloaca 21 (91.3%) 
Tail 20 (87%) 
Cranial 1/3 23 (100%) 
Middle 1/3 23 (100%) 
Caudal 1/3 23 (100%) 
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Table 2.8. Median histologic severity score of each survey section from 23 Lake Erie watersnakes (Nerodia sipedon insularum). 
 
Body Area Median Histologic 
Severity Score 
Minimum Histologic Severity 
Score 
Maximum Histologic 
Severity Score 
Head 3 0 3 
1 1 0 3 
2 1 0 3 
3 1 0 3 
4 1 0 2 
5 1 0 3 
6 1 0 3 
7 1 0 3 
8 1 0 2 
9 1 0 3 
Cloaca 1 0 3 
Tail 2 0 3 
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Table 2.9. Prevalence of SFD-associated lesions (# of positive sections) and histological features in 23 Lake Erie watersnakes 
(Nerodia sipedon insularum).  
 
Snake # of Positive Sections Sum of Severity Scores Arthroconidia Present? 
18132 10 23 Yes 
18133 11 16 Yes 
18134 12 28 Yes 
18135 12 16 Yes 
18136 11 14 Yes 
18137 11 13 Yes 
18146 12 23 Yes 
18147 11 20 Yes 
18148 12 19 Yes 
18158 8 9 Yes 
1910 12 20 Yes 
1911 12 31 Yes 
1912 12 15 Yes 
1913 10 10 Yes 
1914 12 22 Yes 
1915 9 12 No 
1916 8 11 No 
1917 11 21 Yes 
1918 12 16 Yes 
1919 11 15 No 
1920 12 14 Yes 
1921 12 19 Yes 
1922 12 14 Yes 
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Table 2.10. Pearson’s correlation calculated between total number of sections with SFD-associated lesions and overall cutaneous 
histologic severity grade from 23 Lake Erie watersnakes (Nerodia sipedon insularum).  
 
Survey Location Correlation  P value 
Head 0.333 0.120 
1 0.869 0.000 
2 0.643 0.001 
3 0.742 0.000 
4 0.712 0.000 
5 0.643 0.001 
6 0.713 0.000 
7 0.744 0.000 
8 0.570 0.005 
9 0.548 0.007 
Cloaca 0.435 0.038 
Tail 0.554 0.006 
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Table 2.11. Number of survey sections within each cutaneous severity grade category that had evidence of subclinical vs. cutaneous 
gross lesions.   
 
Histologic 
Grade 
No Lesions.         
(# of sections) 
Subclinical Lesions (# 
of sections) 
Cutaneous Gross 
Lesions (# of 
sections) 
0 18 (85.7%) 0 (0%) 3 (14.3%) 
1 0 (0%) 98 (67.1%) 48 (32.9%) 
2 0 (0%) 17 (23.6%) 55 (76.4%) 
3 0 (0%) 2 (5.4%) 35 (94.6%) 
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Table 2.12. Comorbidities observed within the 23 Lake Erie watersnakes (Nerodia sipedon insularum). 
 
 
 
 
 
 
 
Central 
Nervous 
System 
 
Heart 
 
Lungs 
 
Liver 
 
Splenopancreas 
 
Gastrointestinal 
system 
 
Kidneys 
 
Subcutis 
 
Skin 
 
Visceral 
Adipose 
 
heterophilic 
encephalitis 
(4.3%) 
Vascular 
basement 
membrane 
mineralizati
on (4.3%) 
 
Nematodes 
(61%) 
Heterophilic 
interstitial 
pneumonia 
(4.3%) 
Granuloma 
(21.7%) 
Pulmonary 
fibrosis (4.3%) 
Vascular 
basement 
membrane 
mineralizatio
n (4.3%) 
Fibrinonecroti
zing hepatitis 
(8.7%) 
Granuloma 
(17.4%) 
Heterophilic 
hepatitis 
(4.3%) 
Vacuolar 
change 
(13%) 
Granuloma 
(8.7%) 
Fibrinonecrotizin
g pancreatitis 
(4.3%) 
Heterophilic 
splenitis (17.4%) 
Multifocal 
necrosis (4.3%) 
Amyloidosis 
(4.3%) 
Vascular basement 
membrane 
mineralization 
(4.3%) 
Nematodes (39%) 
Fibrinonecrotizing 
and hemorrhagic 
peritonitis (4.3%) 
Heterophilic gastritis 
(4.3%) 
Mesenteric 
granuloma (4.3%) 
Heterophilic enteritis 
(4.3%) 
Ciliated protozoa 
(4.3%) 
Coccidia (13%) 
Heterophilic colitis 
(4.3%) 
Lymphoplasmacytic 
colitis (4.3%) 
Vascular 
basement 
membrane 
mineralization 
(4.3%) 
Intratubular 
mineral (8.7%) 
Granuloma 
(4.3%) 
Lymphoplasma
cytic interstitial 
nephritis (4.3%) 
Multifocal 
tubular necrosis 
with renal gout 
(4.3%) 
Granuloma 
(13%) 
Bacteria 
(100%) 
Mites 
(21.7%) 
Algae 
(4.3%) 
decreased 
visceral 
adipose tissue 
stores (82.6%) 
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Table 2.13. All comorbidities observed in 23 Lake Erie watersnakes (Nerodia sipedon insularum). NSL= no significant lesions.  
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Table 2.13 (continued) 
 
 
57 
CHAPTER 3: CONCLUSIONS AND FUTURE DIRECTIONS 
 The goal of this project was to characterize the pathology of ophidiomycosis (snake 
fungal disease, SFD), an emerging infectious disease that is the cause of  individual and 
population mortality events. The study focused on the pathology of SFD in Lake Erie 
watersnakes. In the first hypothesis, the distribution and prevalence of gross and histologic 
disease was documented. The lesions identified in the first objective were characterized using a 
recently developed grading scheme that allowed objective documentation of cutaneous severity. 
With this data, it was found that as overall cutaneous severity of an individual increased, 
cutaneous lesions tended to be more widely distributed.  This study also demonstrated that 
subclinical disease was present in 45.3% of survey sections throughout this cohort of snakes. The 
high prevalence of subclinical disease in this group highlights the need for pathologic assessment 
in addition to molecular/microbiological testing to confirm SFD and demonstrates that solely 
relying on qPCR may underestimate disease prevalence.  
 Future study should be aimed at detecting O. ophiodiicola in characteristic subclinical 
cutaneous lesions. During this study, cutaneous swabs were taken at each of the survey locations 
(head, tail, cloaca, and nine body sections), but qPCR testing of these swabs was beyond the 
scope of this project. Detecting O. ophiodiicola in these lesions would establish a direct link that 
can be applied to characterize disease progression. The preferred approach to characterize these 
lesions would be an experimental challenge study. Ideally, a cohort of untreated, naïve snakes 
could be inoculated in multiple areas of the body with O. ophiodiicola either simply on the 
epidermal surface or facilitated by a break in the epidermis. Skin biopsies could then be taken 
sequentially in order to document the temporal changes associated with each phase of the disease 
 
 
58 
process. Differences in success of individuals to resolve characteristic lesions could then be used 
to identify early less invasive diagnostic tests or treatment options that improve success.  
 Results of this study showed that cutaneous severity did not correlate with the presence or 
absence of visceral granulomas. One of the major limitations of this study was that visceral 
granulomas were not confirmed to be directly associated with O. ophiodiicola infection. If these 
granulomas truly represent systemic infection by O. ophiodiicola, this would provide additional 
documentation with regard to the prevalence of true internal lesions, which is rarely reported in 
the literature. Confirming that these granulomas are directly caused by O. ophiodiicola would 
also add further support to our conclusion that multiple modalities of testing are needed to 
confirm SFD, as a cutaneous swab would not be adequate to rule out SFD in these cases. Future 
work should be directed at qPCR of these visceral granulomas for O. ophiodiicola, Mycobacteria 
sp., and other bacteria such as Morganella sp., Salmonella sp., and Chlamydophila sp. to rule out 
a coinfection. Definitively diagnosing the underlying cause of these visceral granulomas is 
pertinent to understanding the pathogenesis of systemic infection and/or understanding how 
systemic granuloma formation is capable of contributing to mortality.  
 The results of this study demonstrated numerous comorbidities within this sample 
population. Histologic characterization of these findings suggested that many common 
comorbidities (e.g. pulmonary and gastrointestinal nematodes) were likely incidental and did not 
significantly contribute to the animal’s death. Based on these findings, it was concluded that SFD 
alone is capable of causing individual mortality. However, the mechanism by which it does so 
remains unclear. This thesis showed that the most prevalent comorbidity was a marked reduction 
in visceral adipose. This finding may indicate a persistent negative energy balance secondary to 
SFD that could explain how O. ophiodiicola infection alone could lead to death. Future studies 
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should include wider assessment of body condition, including quantification of muscle mass. A 
future challenge study could use 3 groups of snakes offered small, moderate, and high caloric 
intake.  These individuals could then be assessed for body condition by measuring abdominal 
girth measurement, muscle mass, and body weight. This could be investigated by using 
computed tomography or the use of metabolomic methods. Results may also provide insight as 
to whether or not available nutrition is associated with resolution of SFD.  
  This study was focused on characterization of SFD specifically in Lake Erie 
watersnakes. A pertinent future direction would include repeating this same protocol on snakes 
of varying species and natural habitats in order to see if the results stated in Chapter 2 hold true. 
During this study period, 13 additional snakes, including three Eastern Massasauga rattlesnakes 
(Sistrurus catenatus), four prairie kingsnakes (Lampropeltis calligaster), two blue racers 
(Coluber constrictor foxii), one black rat snake (Pantherophis obsoletus), one yellow rat snake 
(Pantherophis alleghaniensis), one timber rattlesnake (Crotalus horridus),  and one Eastern fox 
snake (Pantherophis gloydi) were examined using this study’s protocol; however, because of the 
variability in species, natural habitat, length in captivity, these individuals were not included in 
the data set. Continued recruitment of snakes of various species such as the ones previously 
listed, particularly if variables can be controlled, may offer insight into how the disease may 
manifest in different species and environments.  
 This thesis provides a basis for future consideration in studies evaluating prevalence of 
SFD in individual snakes or snake populations by providing a standardized approach to gross and 
histopathologic examination as well as highlighting the high prevalence of subclinical disease 
and necessity of using fungal culture/PCR, gross findings, and histopathology in documentation 
of disease. By documenting a high prevalence of subclinical disease, this study also informs 
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those tasked with providing effective treatment to SFD affected individuals that a lack of, or 
resolution of, gross lesions does not imply resolution of disease. The work done in this study 
provides a starting point for veterinary pathologists, clinicians, and researchers alike to collect 
appropriate samples to accurately identify and document SFD in both treated and untreated 
snakes.   
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